![Kevin Ens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Ens
Chief Operating Officer at Metabolomic Technologies, Inc.
Kevin Ens active positions
Companies | Position | Start | End |
---|---|---|---|
Metabolomic Technologies, Inc.
![]() Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Chief Operating Officer | 2019-06-30 | - |
Career history of Kevin Ens
Statistics
International
Canada | 2 |
Operational
Chief Operating Officer | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Metabolomic Technologies, Inc.
![]() Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Commercial Services |
- Stock Market
- Insiders
- Kevin Ens
- Experience